Documents Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry...

Slide 1 Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra Mandrekar,…

Documents Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials

Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra Mandrekar,…